ArticleScientific reports2021

A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma.

Kieran G Foley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.